MICS & non-penetrating glaucoma surgery combination okay

Article

Microincisional bimanual phacoemulsification and non-penetrating glaucoma surgery appears to be a safe option for patients with glaucoma and co-existing cataract, according to a Turkish study.

Microincisional bimanual phacoemulsification and non-penetrating glaucoma surgery appears to be a safe option for patients with glaucoma and co-existing cataract, according to a Turkish study.

Mehmet Baykara and colleagues from Uludag University, Bursa, Turkey performed microincisional bimanual phacoemulsification with a sleeveless phaco needle and irrigating chopper in combination with non-penetrating glaucoma surgery. Phacoemulsification was performed through two clear corneal incisions in order to spare the viscocanalostomy site from trauma.

The first 12 consecutive eyes of 12 patients who had the combined procedure had significantly lower intraocular pressure. Slit anterior chamber was seen in one eye one day postoperatively and no other complications were observed.

The authors of this study believe that combined microincisional bimanual phaco and non-penetrating glaucoma surgery is an effective option for patients with co-existing glaucoma and cataract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.